Prospective Clinical Research of the Efficacy of Platelet-rich Plasma in the Outpatient-based Treatment of Rotator Cuff Tendinopathy |
Lee, Ho-Won
(Department of Orthopedic Surgery, Hallym University Kangnam Sacred Heart Hospital)
Choi, Kyung-Ho (Department of Orthopedic Surgery, Hallym University Kangnam Sacred Heart Hospital) Kim, Jung-Youn (Department of Orthopedic Surgery, Hallym University Kangnam Sacred Heart Hospital) Yang, Ik (Department of Radiology, Hallym University Kangnam Sacred Heart Hospital) Noh, Kyu-Cheol (Department of Orthopedic Surgery, Hallym University Kangnam Sacred Heart Hospital) |
1 | Noh KC, Liu XN, Zhuan Z, et al. Leukocyte-poor platelet-rich plasma-derived growth factors enhance human fibroblast proliferation in vitro. Clin Orthop Surg. 2018;10(2):240-7. doi:10.4055/cios.2018.10.2.240. DOI |
2 | von Wehren L, Blanke F, Todorov A, Heisterbach P, Sailer J, Majewski M. The effect of subacromial injections of autologous conditioned plasma versus cortisone for the treatment of symptomatic partial rotator cuff tears. Knee Surg Sports Traumatol Arthrosc. 2016;24(12):3787-92. doi: 10.1007/s00167-015-3651-3. DOI |
3 | Magalon J, Bausset O, Serratrice N, et al. Characterization and comparison of 5 platelet-rich plasma preparations in a singledonor model. Arthroscopy. 2014;30(5):629-38. doi: 10.1016/j.arthro.2014.02.020. DOI |
4 | McCarrel TM, Minas T, Fortier LA. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J Bone Joint Surg Am. 2012;94(19):e143(1-8). doi:10.2106/JBJS.L.00019. DOI |
5 | Anitua E, Zalduendo M, Troya M, Padilla S, Orive G. Leukocyte inclusion within a platelet rich plasma-derived fibrin scaffold stimulates a more pro-inflammatory environment and alters fibrin properties. PLoS One. 2015;10(3):e0121713. doi:10.1371/journal.pone.0121713. DOI |
6 | Cross JA, Cole BJ, Spatny KP, et al. Leukocyte-reduced plateletrich plasma normalizes matrix metabolism in torn human rotator cuff tendons. Am J Sports Med. 2015;43(12):2898-906. doi: 10.1177/0363546515608157. DOI |
7 | Carmona JU, Lopez C, Sandoval JA. Review of the currently available systems to obtain platelet related products to treat equine musculoskeletal injuries. Recent Pat Regen Med. 2013;3(2):148-59. doi: 10.2174/2210296511303020005. DOI |
8 | DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy. 2012;28(7):998-1009. doi: 10.1016/j.arthro.2012.04.148. DOI |
9 | Stenhouse G, Sookur P, Watson M. Do blood growth factors offer additional benefit in refractory lateral epicondylitis? A prospective, randomized pilot trial of dry needling as a standalone procedure versus dry needling and autologous conditioned plasma. Skeletal Radiol. 2013;42(11):1515-20. doi:10.1007/s00256-013-1691-7. DOI |
10 | Fitzpatrick J, Bulsara M, Zheng MH. The effectiveness of platelet-rich plasma in the treatment of tendinopathy: a metaanalysis of randomized controlled clinical trials. Am J Sports Med. 2017;45(1):226-33. doi: 10.1177/0363546516643716. DOI |
11 | Yan R, Gu Y, Ran J, et al. Intratendon delivery of leukocytepoor platelet-rich plasma improves healing compared with leukocyte-rich platelet-rich plasma in a rabbit achilles tendinopathy model. Am J Sports Med. 2017;45(8):1909-20. doi:10.1177/0363546517694357. DOI |
12 | Lim W, Park SH, Kim B, Kang SW, Lee JW, Moon YL. Relationship of cytokine levels and clinical effect on platelet-rich plasma-treated lateral epicondylitis. J Orthop Res. 2018;36(3):913-20. doi: 10.1002/jor.23714. DOI |
13 | Mitchell C, Adebajo A, Hay E, Carr A. Shoulder pain: diagnosis and management in primary care. BMJ. 2005;331(7525):1124-8. doi: 10.1136/bmj.331.7525.1124. DOI |
14 | Kaux JF, Forthomme B, Goff CL, Crielaard JM, Croisier JL. Current opinions on tendinopathy. J Sports Sci Med. 2011;10(2):238-53. |
15 | Seitz AL, McClure PW, Finucane S, Boardman ND 3rd, Michener LA. Mechanisms of rotator cuff tendinopathy: intrinsic, extrinsic, or both? Clin Biomech (Bristol, Avon). 2011;26(1):1-12. doi: 10.1016/j.clinbiomech.2010.08.001. DOI |
16 | Lewis JS. Rotator cuff tendinopathy/subacromial impingement syndrome: is it time for a new method of assessment? Br J Sports Med. 2009;43(4):259-64. doi: 10.1136/bjsm.2008.052183. DOI |
17 | Hermans J, Luime JJ, Meuffels DE, Reijman M, Simel DL, Bierma-Zeinstra SM. Does this patient with shoulder pain have rotator cuff disease?: the rational clinical examination systematic review. JAMA. 2013;310(8):837-47. doi: 10.1001/jama.2013.276187. DOI |
18 | Jo CH, Shin WH, Park JW, Shin JS, Kim JE. Degree of tendon degeneration and stage of rotator cuff disease. Knee Surg Sports Traumatol Arthrosc. 2017;25(7):2100-8. doi: 10.1007/s00167-016-4376-7. DOI |
19 | Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet. 2010;376(9754):1751-67. doi: 10.1016/S0140-6736(10)61160-9. DOI |
20 | Browning DG, Desai MM. Rotator cuff injuries and treatment. Prim Care. 2004;31(4):807-29. doi: 10.1016/j.pop.2004.08.004. DOI |
21 | Engebretsen L, Steffen K, Alsousou J, et al. IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med. 2010;44(15):1072-81. doi: 10.1136/bjsm.2010.079822. DOI |
22 | Alsousou J, Thompson M, Hulley P, Noble A, Willett K. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg Br. 2009;91(8):987-96. doi: 10.1302/0301-620X.91B8.22546. |
23 | Pietrzak WS, Eppley BL. Platelet rich plasma: biology and new technology. J Craniofac Surg. 2005;16(6):1043-54. doi:10.1097/01.scs.0000186454.07097.bf. DOI |
24 | Hsu C, Chang J. Clinical implications of growth factors in flexor tendon wound healing. J Hand Surg Am. 2004;29(4):551-63. doi: 10.1016/j.jhsa.2004.04.020. DOI |
25 | Hudgens JL, Sugg KB, Grekin JA, Gumucio JP, Bedi A, Mendias CL. Platelet-rich plasma activates proinflammatory signaling pathways and induces oxidative stress in tendon fibroblasts. Am J Sports Med. 2016;44(8):1931-40. doi: 10.1177/0363546516637176. DOI |
26 | Zhang J, Middleton KK, Fu FH, Im HJ, Wang JH. HGF mediates the anti-inflammatory effects of PRP on injured tendons. PLoS One. 2013;8(6):e67303. doi: 10.1371/journal.pone.0067303. DOI |
27 | de Vos RJ, Weir A, van Schie HT, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA. 2010;303(2):144-9. doi: 10.1001/jama.2009.1986. DOI |
28 | Nguyen RT, Borg-Stein J, McInnis K. Applications of plateletrich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM R. 2011;3(3):226-50. doi:10.1016/j.pmrj.2010.11.007. DOI |
29 | Zhang L, Chen S, Chang P, et al. Harmful effects of leukocyterich platelet-rich plasma on rabbit tendon stem cells in vitro. Am J Sports Med. 2016;44(8):1941-51. doi: 10.1177/0363546516644718. DOI |
30 | Zhou Y, Zhang J, Wu H, Hogan MV, Wang JH. The differential effects of leukocyte-containing and pure platelet-rich plasma (PRP) on tendon stem/progenitor cells - implications of PRP application for the clinical treatment of tendon injuries. Stem Cell Res Ther. 2015;6:173. doi: 10.1186/s13287-015-0172-4. DOI |
31 | Constant CR, Murley AH. A clinical method of functional assessment of the shoulder. Clin Orthop Relat Res. 1987;(214):160-4. |
32 | Michener LA, McClure PW, Sennett BJ. American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form, patient self-report section: reliability, validity, and responsiveness. J Shoulder Elbow Surg. 2002;11(6):587-94. doi:10.1067/mse.2002.127096. DOI |
33 | Wesner M, Defreitas T, Bredy H, et al. A pilot study evaluating the effectiveness of platelet-rich plasma therapy for treating degenerative tendinopathies: a randomized control trial with synchronous observational cohort. PLoS One. 2016;11(2):e0147842. doi: 10.1371/journal.pone.0147842. DOI |
34 | Middleton KK, Barro V, Muller B, Terada S, Fu FH. Evaluation of the effects of platelet-rich plasma (PRP) therapy involved in the healing of sports-related soft tissue injuries. Iowa Orthop J. 2012;32:150-63. |
35 | Koester MC, Dunn WR, Kuhn JE, Spindler KP. The efficacy of subacromial corticosteroid injection in the treatment of rotator cuff disease: a systematic review. J Am Acad Orthop Surg. 2007;15(1):3-11. DOI |
36 | Kesikburun S, Tan AK, Yilmaz B, Yasar E, Yazicioglu K. Plateletrich plasma injections in the treatment of chronic rotator cuff tendinopathy: a randomized controlled trial with 1-year follow-up. Am J Sports Med. 2013;41(11):2609-16. doi:10.1177/0363546513496542. DOI |
37 | Rha DW, Park GY, Kim YK, Kim MT, Lee SC. Comparison of the therapeutic effects of ultrasound-guided platelet-rich plasma injection and dry needling in rotator cuff disease: a randomized controlled trial. Clin Rehabil. 2013;27(2):113-22. doi: 10.1177/0269215512448388. DOI |
38 | Say F, Gurler D, Bulbul M. Platelet-rich plasma versus steroid injection for subacromial impingement syndrome. J Orthop Surg (Hong Kong). 2016;24(1):62-6. doi: 10.1177/230949901602400115. DOI |
39 | Jo CH, Lee SY, Yoon KS, Oh S, Shin S. Allogenic pure platelet-rich plasma therapy for rotator cuff disease: a bench and bed study. Am J Sports Med. 2018;46:3142-54. doi:10.1177/0363546518800268. DOI |
40 | Moraes VY, Lenza M, Tamaoki MJ, Faloppa F, Belloti JC. Platelet-rich therapies for musculoskeletal soft tissue injuries. Cochrane Database Syst Rev. 2014;(4):CD010071. doi:10.1002/14651858.CD010071.pub3. |
41 | Fitzpatrick J, Bulsara M, Zheng MH. Effectiveness of PRP in the treatment of tendinopathy: response. Am J Sports Med. 2016;44(10):NP53. doi: 10.1177/0363546516669312. DOI |
![]() |